FDA Advisory Committee to Discuss COVID Vaccine Regimens
FDA Grants Approval for HIV Treatment to Fight Drug Resistance
Pharmacies Limit Children’s Pain Medication Purchases
Merck and Moderna Find Success with Cancer Vaccine Clinical Trial
FDA Approves New Adjunctive Treatment for Depression
COVID Vaccines Have Prevented 3,255,656 Deaths
Projected Shortage of Non-Human Primates May Impact Drug Development
Janssen Submits Biologics License Application for Talquetamab
Amgen’s $27.8 Billion Rare Disease Drug Acquisition
Developing Next-Generation COVID Vaccines, an Urgent Need
Navigating Cold and Flu Medication Shortages
AHA Funds Research Network to Advance Clinical Trial Diversity
ACMA Announces Board Certification Program for Biologics, Biosimilars
Pfizer Invests $750M in Michigan Pharmaceutical Manufacturing Expansion
Oral Butyrate Supplementation Treats Pediatric Obesity
Biosimilars in the US Cost 2.74 Times More Than in Other Countries
Comparing Buprenorphine and Methadone for OUD During Pregnancy
Eli Lilly Acquires Akouos in Approximately $487 Million Transaction
FDA Approves $3.5 Million per Dose Hemophilia B Gene Therapy
FDA Investigates Prolia’s Association with Severe Hypocalcemia
FDA Grants IND Approval for Prostate Cancer Clinical Trial
NYC Vaccination Campaigns Saved $27.96 Billion in Healthcare Expenses
Wound Infiltration May Reduce Pain Following Cesarean Delivery
Understanding the Correlation Between COVID-19 and Flu Vaccination
FDA Approves ELAHERE for Ovarian Cancer
FDA Clears Clinical Trials on Investigational New Drug for ALS
FDA Approves TZIELD to Delay Stage 3 Type 1 Diabetes
FDA Recommends New Asthma Rescue Treatment
Citeline and Norstella Merger Creates $5B Pharmaceutical Technology Company
A Single Dose of Psilocybin Can Reduce MADRS Score
Study Finds Increased Prevalence of Nonpharmacological Pain Treatment
How Mesenchymal Stem Cells May Reduce the Need for Antirejection Drugs
J&J Preps for Consumer Health Spin-Off, Purchases Abiomed for $16.6B
First Humans Transfused with Lab-Grown Blood
Pfizer Plans to Nearly Quadruple COVID Vaccine Costs
FDA Approves Investigational Drug Application for Bi-Functional Fusion Protein
Valisure Petitions FDA to Recall Dry Shampoos
RSV Cases Flood Children’s Hospitals as Pfizer Announces Promising Vaccine
COVID-19 Vaccine Side Effects Are Associated with Antibody Response
Motivational Interventions May Improve SUD Recovery
Nearly 13% of Oral Anticancer Prescriptions Are Not Received
US Department of Defense Grants $2.97 Million to Treventis
FDA Data Shows That 125 Drugs Are Currently in Short Supply
FDA Awards 19 Grants for Rare Disease Research
Unilever Dry Shampoos Recalled Due to Carcinogens
Etripamil Phase III Clinical Trials Are Successful
AMA Analysis Finds Variations in PBM Competition
Novartis Is Losing Its Battle Against a Generic Drug for MS
NIH Awarded Intravacc $14.6 Million to Develop a Gonorrhea Vaccine
Orexo Pharmaceuticals Announces Phase I Clinical Study Data
Diversifying Clinical Trials through Telehealth Platforms
How Excluding Disabled Populations from Clinical Trials Impacts Care
J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission
KFF Survey Reveals Confusion About Bivalent COVID Boosters
Walmart Launches Clinical Research Mission
Pharmaceutical Industry Is Developing Almost 800 Chronic Disease Drugs
COVID-19 Vaccination Alters Menstrual Cycle Length
President Biden Calls for Reform on Marijuana Regulation
Kroger Health to End Express Scripts Pharmacy Provider Agreement
Biologics and Biosimilars Intelligence Consortium Awarded $1.3 Million
FDA Approves Drug for Open-Angle Glaucoma and Ocular Hypertension
Drug Costs Are Not Justified by Research and Development Costs
Fish Oil Supplements Associated with Risk of Atrial Fibrillation
FDA Approves Relyvrio for ALS Treatment
How Digital Companions, Therapeutics Are Changing Healthcare
Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement
How Federal and State Laws Have Hindered Access to OUD Treatment
FDA Approved Psilocybin Investigational New Drug Application
Digital Health Tools Are Perceived as an Advantage to 93% of Physicians
US FDA Accelerated Approval for 48 Non-oncology Drugs
Walgreens’ $1.67-Billion Specialty Pharmacy and Home Health Play
How a New Antiviral Therapy May Prevent COVID-19 Transmission
McKesson Plans to Acquire Rx Savings Solutions
Pregnant and Lactating Individuals Tolerate COVID Vaccine Boosters
FDA and NIH Launch Partnership for Rare Neurodegenerative Diseases
Amgen’s Immunotherapy for Lung Cancer Reduces Disease Progression by 34%
Biden Administration Appoints Renee Wegrzyn as Director of the ARPA-H
Medications in the US Are More Widely Available than in Germany
Democratizing Access to Clinical Trials through Remote Patient Monitoring
Psilocybin-Assisted Psychotherapy Reduces Heavy Drinking
Glucocorticoids Alter Brain Volume and White Matter Microstructure
Federal Judge Rules against Mandated HIV PrEP Coverage
Paxlovid Advantageous for Elderly COVID-19 Patients, Ineffective in Younger Adults
Stroke Prevention Study to Analyze Benefits of Wearable Devices
FDA Announces That 35% of Drug Samples Were Non-Compliant
FDA Approves Bivalent COVID Boosters
FDA Approved the Use of Omnipod 5 for Children Over 2
WHO Recommends Use of Monoclonal Antibodies in Ebola Treatment
FDA Approved AUVELITY for Major Depressive Disorder in Adults
FDA Approves Mirena for 8 Years
Integrating Real-World and Clinical Trial Data to Improve Patient Outcomes
FDA Expands Emergency Use Authorization for Novavax COVID Vaccine in Kids
Biden Administration Secures COVID-19 Booster Shots for Use This Fall
Judge Rules against CVS, Walgreens, and Walmart in Ohio Opioid Case
FDA Approves Cell-Based Gene Therapy for Patients with Beta Thalassemia
FDA Approves the Sale of Hearing Aids over the Counter
CVS Implements Time Delay Safes for Controlled Substances
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
California Allots $100 Million to Produce Insulin, Improving Access
FDA Considers Dividing Monkeypox Vaccine Doses
Hormonal Male Birth Control Product Reaches Late-Phase Clinical Trials
Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products
Fourth COVID Shot Reduced the Risk of Infection by 12.9%
Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge
Antibiotic Overprescription Is Associated with Worse CKD Outcomes
Lyons Magnus Recalls Products due to Microbial Contamination
COVID-19 Vaccination Reduced the Risk of Reinfection by Approximately 50%
Fall COVID Vaccine Boosters Could Prevent over 100,000 Deaths
Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen
$4.25 Billion Opioid Settlement by Teva Pharmaceuticals
HHS Statement on FDA Approval of Bavarian Nordic Monkeypox Vaccine
Astellas and Seagen Announce Results on a Drug for Urothelial Cancer
Paxlovid Reduces Patient Hospitalization Risk by 5 Times
Decreased COVID-19 Vaccination Rates: A Pediatric Health Risk
Increased Rates of Non-Opioid Prescription Following CDC Guidelines
Global Vaccination Coverage Dropped 5% in 2021
FDA Grants Abbott Permission to Investigate DBS in Managing Depression
Aid Access Discusses Making Abortion Pill Available as Contraception
Depression, Anxiety Prescriptions Soar During Coronavirus Pandemic
CDC Recommends Novavax COVID Vaccine
Verve Doses First Patient with Investigational Gene-Editing Medicine
Orexo Pharmaceuticals Announces Nasal Adrenaline Clinical Development
Decentralization Tools May Improve Cancer Clinical Trial Enrollment
HHS Issues Pharmacies’ Obligation to Ensure Access to Reproductive Care
$354M BARDA Contract for Pharmaceutical Manufacturing Goes Unfulfilled
Psychotropic Medications Linked to an Increased Risk of Parkinson’s
HRA Pharma Submits FDA Application for First OTC Birth Control Pill
Decibel Therapeutics Announces Results of DB-020 Clinical Trial
FDA Expands EUA to Allow Pharmacists to Prescribe Paxlovid
FDA Releases Drug Safety Communication regarding Cancer Drug, Copiktra
FDA Approves New Treatment for Large B-Cell Lymphoma
FDA Approves New Weight Management Drug for Kids over 12
HPV Vaccine Rates Increase among Adolescents
Radiologists Look for Ways to Conserve amidst the Dye Shortage
Antitrust Lawsuit against Generic Pharmaceutical Companies Is Amended
Women Are Underrepresented in Clinical Trials, Leading to Health Inequity
USPTF Updates Recommendations on Supplements to Prevent Cancer
Epilepsy Drug Prices Have Increased by 277% in the Past Decade
How Data, Apps, and Hackers Are Reshaping Healthcare
FDA Expanded Approval of Skyrizi for Treatment of Crohn’s Disease
Vagus Nerve Stimulation Augments Behaviors in Epilepsy Patients
Pfizer Acquires ReViral for $525M, Renews Pharma Acquisition Spree
FDA Approved Weight-Management Treatment for Bardet–Biedl Syndrome
Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes
Could the Approval of Albrioza by Health Canada for ALS Impact the FDA Ruling?
FDA Advisory Board Unanimously Votes to Approve Pfizer COVID Vaccine for Kids under 5
FDA Accepts Biologic Application for Keytruda Treatment of Lung Cancer
Olumiant Becomes the First FDA-Approved Systemic Treatment for Alopecia Areata
Eli Lilly Sued by Whistleblower for Pharmaceutical Manufacturing Issue
Bluebird Bio’s Rare Disease Gene Therapies Recommended for FDA Approval
US FDA Approves GSK’s Priorix Measles, Mumps, and Rubella Vaccine
CDC Report Links People Seeking Substance Misuse Treatment to Psychiatric Issues
FDA Recommends Emergency Use for Novavax Coronavirus Vaccine
Researchers Discover Promising Compound That Kills Hard-to-Treat Cancer Cells
FDA Refuses to File Aeglea Biologics License Application
Pfizer-BioNTech’s Expanding Coronavirus Vaccine FDA Approval
Nephron Pharmaceuticals Recalls 2.1 Million Doses of Medicine, Medical Equipment
Study Finds Vaccination During Pregnancy Decreases Baby’s COVID-19 Risk
Novartis Gains FDA Approval for Follicular Lymphoma Cell Therapy
Academia Partners with Pharma to Discover New SARS-CoV-2 Drug Treatments
Coronavirus Rebound After Pfizer’s Paxlovid Oral Antiviral Drug
Eli Lilly Invest $2.1B in Indiana Pharmaceutical Manufacturing
FDA Approves First Drug for Chronic Disease Eosinophilic Esophagitis
Hospital Contrast Dye Shortage Results in Rationed Medical Imaging Care
Pfizer Acquires Biohaven Pharmaceutical for $11.6 Billion in Cash
FDA Issues Guidance for Dietary Supplement Marketplace
FDA Amends EUA For Pfizer-BioNTech’s COVID-19 Vaccine Booster
Prescription Drug Manufacturer Pre-Rebate Costs Skyrocket
FDA Lifts Clinical Hold on Gilead’s HIV Treatment, Lenacapavir
FDA Approves Eli Lilly and Company’s Type 2 Diabetes Injectable
Bristol Myers Squibb’s Drug Effective in Plaque Psoriasis Patients
Roche, Global Fund to Build Diagnostic Capacity of HIV, Tuberculosis
J&J Appoints Thibaut Mongon CEO of New Consumer Health Company
Janssen Pharmaceuticals Terminates Collaboration in Hepatitis B, HPV
Novo Nordisk, Flagship to Develop Rare Disease Treatments
FDA Limits Use of Johnson & Johnson COVID-19 Vaccine
Real-World Evidence Shows Pfizer’s Ibrance Improves Breast Cancer
Pfizer’s COVID-19 Treatment Reduces Disease by 37% Post-Exposure
Bristol Myers Ends Clinical Program for Combination Drug Therapy
Novartis’ Antibody Boosts Survival for Squamous Cell Carcinoma
Gilead, Dragonfly to Advance Immunotherapies in Oncology
Eli Lilly’s Obesity Drug Elicits 22.5% of Weight Loss in Adults
Roche’s Drug Improves Infants with Type 1 Spinal Muscular Atrophy
FDA Approves AstraZeneca’s Drug for Generalized Myasthenia Gravis
AstraZeneca to Open Drug Research, Development Site in MA
Dr. Vishal Sikka to Join GSK as Non-Executive Director
FDA Expands Approval of COVID-19 Treatment, Remdesivir
FDA Accepts AstraZeneca BLA for Hepatocellular Carcinoma Antibody
Pfizer Reports Positive Phase 2 Data for Lyme Disease Vaccine
Sandoz Launches Generic Drug Combination for Ocular Hypertension
J&J Launches Satellite Center to Tackle Antimicrobial Resistance
FDA Accepts Application for GSK’s Chronic Kidney Disease Drug
FDA Proposes Ban on All Flavored Cigarettes, Cigars
Moderna Appoints Arpa Garay as Chief Commercial Officer
FDA Considers New Strategy to Boost Safe Opioid Disposal
GSK Enters $1.9B Agreement to Develop Rare Cancer Treatments
FDA Issues EUA to First COVID-19 Test Using Breath Samples
FDA Grants Priority Review for Non-Small Cell Lung Cancer Drug
Sanofi’s BTK Inhibitor Effective in Immune Thrombocytopenia Patients
FDA Lifts Hold on Gilead’s MDS, AML Clinical Trials
Moderna Doses Participants in Study of Two Influenza mRNA Vaccines
WHO Recommends Johnson & Johnson’s COVID-19 Vaccine for Booster Use
Sanofi Launches First-in-Pharma Diversity, Equity, Inclusion Board
FDA Issues Draft Guidance to Increase Clinical Trial Diversity
Eli Lilly’s Retevmo Helps Non-Small Cell Lung Cancer Patients
Pfizer to Acquire BioPharma Company to Develop RSV Therapeutics
Michigan Blue Launches Pharmacogenomics Precision Medicine Program
FDA Approves ViiV Healthcare’s HIV-1 Treatment for Children
Sandoz Expands Collaboration in Antimicrobial Resistance Fight
Pfizer Appoints David M. Denton as CFO, Executive Vice President
Merck Expands Broad Access to HPV Vaccines Globally
Moderna Launches Foundation to Promote Access to Quality Care
New Toolkit Supports Digital Endpoints in Drug Development
Roche’s Small Cell Lung Cancer Antibody Fails in Phase 3 Trial
FDA Expands Indication of Long-Acting Injectable HIV Treatment
AstraZeneca to Share New Data on Oncology Treatment Landscape
Gilead Grants $24M to Improve Access, Care for HIV Communities
Merck’s CMV Drug Lowers Reactivation by 88% After Cell Transplant
Pfizer’s S1P Modulator Drug Helps Ulcerative Colitis Patients
FDA Approves Second Dose of Moderna’s COVID-19 Vaccine
FDA Declines Eli Lilly’s Letter for Non-Small Cell Lung Cancer Drug
FDA Approves Bristol Myers Antibody Combination for Melanoma
J&J’s Global Initiatives Improve Disease Detection, Broaden Access
Pfizer’s Ulcerative Colitis Drug Helps Patients in Phase 3 Study
Vivalink’s Biometrics Data Platform Monitors Oncology Patients
Moderna Will Expand mRNA Vaccine Pipeline Through 2 New Programs
Sandoz Acquires Drug Delivery Device Company to Boost Pipeline
Thermo Fisher to Invest $97M to Expand Drug Development Efforts
Pfizer Submits for EUA of Additional COVID-19 Vaccine Booster
Keytruda Boosts Survival Rate for Non-Small Cell Lung Cancer
Novavax Launches 2 Global Vaccine Programs As Educational Tools
AstraZeneca Launches R&D Challenge to Advance Drug Discovery
Boehringer Ingelheim Halts Chronic Kidney Disease Trial
Moderna Doses First Patient in HIV mRNA Vaccine Clinical Trial
Civica to Manufacture Lower-Priced Insulin for Diabetes Patients
Pfizer’s C. Difficile Vaccine Misses Primary Endpoint in Trial
Novo Nordisk Expands Collaboration in Oral Drug Delivery Tech
Pfizer Initiates Phase 2/3 Clinical Trial of COVID-19 Treatment
FDA Approves Boehringer Ingelheim’s Heart Failure Treatment
Moderna Launches Public Health Strategy to Advance mRNA Vaccines
Gilead’s Trodelvy Helps HR/HER2 Metastatic Breast Cancer Patients
AMA Supports Biden’s Medicare Proposal, Prescription Drug Policies
FDA Issues 3 Cancer Clinical Trial Final Guidance Documents
Boehringer Ingelheim, Lifebit Partner to Advance Biomedical Data
FDA Rejects Gilead’s Drug Application for HIV-1 Treatment
UC Berkeley Loses CRISPR Gene-Editing Patent Appeal
AstraZeneca, Alexion, Neurimmune to Develop Rare Disease Antibody
FDA Accepts Bristol Myers’s BLA for Non-Small Cell Lung Cancer Drug
FDA Accepts Application for Pfizer’s Biosimilar to Humira
Nearly Half of All Medicare Drug Prices Increased From 2019-2020
CHMP Recommends Pfizer, Biohaven’s Generic Drug for Migraine Attacks
ACIP Recommends Pfizer’s TBE Vaccine For Individuals Most At Risk
Moderna, Thermo Fisher to Boost mRNA Vaccine Manufacturing
Moderna Expands mRNA Vaccine Pipeline for HSV, VZV, Cancer
GSK Introduces Standalone Consumer Healthcare Company, Haleon
Top-Selling Medicare Part D Prescription Drugs in Recent Years
GSK, Sanofi Seek Approval of COVID-19 Vaccine for Adults
Lilly Launches Campaign to Educate Early Breast Cancer Patients
Gilead’s HIV-1 Drug Achieves High Rates of Virologic Suppression
Moderna, ROVI Expand Collaboration to Boost mRNA Vaccines
Merck’s Keytruda, Chemotherapy Helps High-Risk Breast Cancer
FDA Grants Emergency Authorization For Eli Lilly’s COVID-19 Antibody
AstraZeneca’s Chemotherapy Treatment Improves Prostate Cancer
Bristol Myers Grants $7.9M to Improve Access to Care Across US
Gilead’s COVID-19 Treatment Effective Against Variants of Concern
Merck KGaA to Assess Quris AI Platform for Clinical Prediction
Biogen, Xbrane Develop Preclinical Monoclonal Antibody, Biosimilar
Senate Confirms Robert Califf as FDA Commissioner
FDA Issues Draft Guidance for Development of Non-Opioid Analgesics
Gilead, ViiV Healthcare Enter $1.25B Settlement Over HIV Drug
Abbott Implants Dual-Chamber Leadless Pacemaker in Clinical Trial
Biogen to Develop, Commercialize Genentech’s Bispecific Antibody
Samsung Biologics to Accelerate Growth in Biosimilar Research
Pfizer Confirms Positive Date of Lyme Disease Vaccine Candidate
Pfizer Seeks to Amend EUA of COVID-19 Vaccine to Include Children
FDA Approves Takeda’s Von Willebrand Disease Treatment
FDA Proposes Rule to Strengthen Pharmaceutical Supply Chain
Personalized Immunotherapy Could Treat Metastatic Breast Cancer
CVS Health, Medable Expand Clinical Trial Access, Engagement
CHMP Issues Positive Opinion of Pfizer’s COVID-19 Treatment
Patient, Prescription-Related Factors Linked to Opioid Overdose
FDA Approves Label Update for CAR-T Cell Therapy, Yescarta
Former Head of Pharmaceutical R&D of Roche Joins Pfizer
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine
Eli Lilly Invests $1B in Facility to Boost Access to Medicine in NC
Moderna, IAVI Dose First Patients in Trial of HIV Vaccine Antigens
Opioid Use Disorder Medicine Lacking for Pregnant Women in US Jails
Regeneron Gets FDA Review for Non-Small Cell Lung Cancer Treatment
2020 Drug Price Increase Driven by Generic Drugs, Biosimilars
FDA Expedites Approval of Gilead’s COVID-19 Treatment, Remdesivir
FDA Grants Clearance to Biotricity’s Arrhythmia Monitoring Device
AstraZeneca Combination Treatment Helps Advanced Biliary Tract Cancer
NIH Launches Competition to Boost Neuromodulation Therapies
Pharmacists’ Role to Expand to Direct Patient Care by 2030
The Center for Breakthrough Medicines, UPenn Boost Gene Therapies
Moderna, Carisma Partner to Develop In Vivo Cancer Therapies
Cosette Acquires 8 Prescription Medications from Daiichi Sankyo
Pfizer’s COVID-19 Treatment Shows In Vitro Efficacy Against Omicron
AstraZeneca to Discover Precision Medicines for Undruggable Targets
Pfizer, Beam Focus on Precision Medicine for Rare Diseases
Tony Wood Replaces Hal Barron as GSK’s Chief Executive Officer
Bristol Myers, Century to Develop Allogeneic Cell Therapies
Pfizer’s COVID-19 Vaccine, Pneumococcal Vaccine Helps Older Adults
Johnson & Johnson Taps Microsoft to Expand Digital Surgery Ecosystem
Pfizer, Biohaven to Commercialize Small Molecule Migraine Drugs
Pfizer Gains Access to LPN Tech For mRNA Vaccines, Therapeutics
Sanofi, Exscientia to Research, Develop Small Molecule Drugs
Real-World Evidence Confirms J&J COVID-19 Vaccine Protection
Eli Lilly Enters Partnership for Nucleic Acid Delivery Technology
Moderna Doses First Participant in Study of EBV mRNA Vaccine
Convalescent Plasma Reduces COVID-19 Hospitalizations Nearly 50%
Novartis, Alnylam Leverage siRNA Technology for Liver Disease
Thermo Fisher Acquires PeproTech to Boost Gene Therapy Market
Big Pharma Cooperation Advances Digital Measures, Drug Development
FDA Expands MRI Compatibility for XR Spinal Cord Stimulation
FDA Authorizes Siemens Healthineers COVID-19 Antigen Self-Test
FDA Approves Two Pediatric Indications For J&J’s Xarelto
iQ Group Seeks Approval for Diabetes Care Management Biosensor
FDA Expands Authorization for Pfizer’s COVID-19 Vaccine Booster
South African Study Shows J&J’s COVID-19 Vaccine 85% Effective
Biogen to Reduce Price of Alzheimer’s Disease Treatment by 50%